Merge solidifies sales team for Chinese market

Merge Healthcare has solidified sales operations for ShanghaiCo, and is now doing business as Merge China.

Justin Dearborn, Merge CEO, said that “China has the potential to be our biggest market in a few years.”

Merge China was reacquired after the dissolution of a transfer agreement to Inqgen Technology earlier this month.

Zhong Wang, who leads Merge China, has built a team that includes: Diana Dai, sales manager, and Weiming Li, customer operations manager, will lead business development efforts with Wang; Feng Chen will lead engineering; XinLiang Li will lead customer service, and Wei Chen will lead HR, finance and administration, according to the Milwaukee, Wis.-base company.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.